ResMed launches Lumis series of noninvasive ventilation devices to manage respiratory stability of patients

ResMed (NYSE: RMD) today announced its Lumis™ series of noninvasive ventilation devices that combine personalized, simplified therapy with powerful wireless connected care capabilities. The Lumis series builds upon ResMed's legacy of innovation as a new option for patients with respiratory challenges who are not dependent on continuous ventilation.

"With its ease of use, customization capabilities and wireless connectivity, the Lumis series offers important benefits for patients, clinicians, and home medical equipment providers alike," said Luke Maguire, President of ResMed's Cardio-Respiratory Care Global Business Unit. "Lumis joins ResMed's Stellar and Astral lines as a new entry-level option for care providers to efficiently and effectively manage the respiratory stability of their patients."

The Lumis series comprises the Lumis 100 VPAP S, Lumis 100 VPAP ST and Lumis 150 VPAP ST noninvasive ventilators that support a variety of therapy modes, built-in wireless connectivity, integrated humidification and intuitive simplicity that are the hallmarks of the series.

Individually Responsive and Tailored for Comfort

Lumis ventilators are designed with a broad range of automatic settings making it an ideal choice for a wide variety of respiratory conditions and individual patient preferences. Lumis is the first ResMed ventilation platform with IntelligentAir, a collection of ResMed technologies that can tailor therapy to individual breathing needs, making truly personalized ventilation possible. The complete IntelligentAir suite for Lumis includes iVAPS (ResMed's unique volume-assurance therapy mode), iBR (an intelligent Backup Rate), and AutoEPAP (which maintains upper airway patency), as well as other features to personalize and fine-tune individual patient's synchrony and comfort (Vsync, TiControl, and trigger and cycle settings).

ResMed engineers also kept comfort top of mind when designing Lumis: each device features built-in HumidAir heated humidification capabilities and the popular Climate Control Auto setting, which automatically determines optimal humidification by adjusting to ambient room conditions. Lumis is compatible with ClimateLineAir™ Oxy tubing that allows for added oxygen to be heated and humidified, which is useful for patients with chronic obstructive pulmonary disease. In addition, the Lumis optional Ramp and Ramp Down features can ease the transition onto ventilation and back to spontaneous breathing when therapy is complete.

Connected Care with AirView™

The Lumis series was designed with connected care capabilities that can improve overall patient care and streamline patient monitoring and therapy management. Lumis' built-in wireless connectivity means that clinicians and home medical equipment providers have next-day access to a wide range of their patients' therapy parameters, including blood oxygen saturation when an oximeter is attached. These data, along with therapy statistics and trend data useful for home titration and monitoring, are automatically and securely transmitted to AirView™, ResMed's cloud-based patient management system. AirView also includes a popular Remote Assist feature that providers can use to troubleshoot common therapy questions and change therapy settings remotely.

Built-in Simplicity and Ease-of-Use

Lumis devices are designed for simplicity and ease-of-use right out of the box. Every device comes built for quick setup thanks to an easy-to-read color screen, improved menu format, and simple push-dial navigation. Lumis' QuickNav feature also allows for easy toggling between the settings and monitoring screens to make it easy to see the real-time impact of configuration changes.

Lumis is compatible with all ResMed Air Solutions accessories, including the popular AirFit mask series, to allow for personalized therapy as well as streamlined home medical equipment inventory management.

The Lumis series is launching in select European markets today, and a global rollout is planned in additional regions throughout 2015 and early 2016.

Source:

ResMed Inc.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    ResMed Corp. (2019, June 20). ResMed launches Lumis series of noninvasive ventilation devices to manage respiratory stability of patients. News-Medical. Retrieved on November 14, 2024 from https://www.news-medical.net/news/20150430/ResMed-launches-Lumis-series-of-noninvasive-ventilation-devices-to-manage-respiratory-stability-of-patients.aspx.

  • MLA

    ResMed Corp. "ResMed launches Lumis series of noninvasive ventilation devices to manage respiratory stability of patients". News-Medical. 14 November 2024. <https://www.news-medical.net/news/20150430/ResMed-launches-Lumis-series-of-noninvasive-ventilation-devices-to-manage-respiratory-stability-of-patients.aspx>.

  • Chicago

    ResMed Corp. "ResMed launches Lumis series of noninvasive ventilation devices to manage respiratory stability of patients". News-Medical. https://www.news-medical.net/news/20150430/ResMed-launches-Lumis-series-of-noninvasive-ventilation-devices-to-manage-respiratory-stability-of-patients.aspx. (accessed November 14, 2024).

  • Harvard

    ResMed Corp. 2019. ResMed launches Lumis series of noninvasive ventilation devices to manage respiratory stability of patients. News-Medical, viewed 14 November 2024, https://www.news-medical.net/news/20150430/ResMed-launches-Lumis-series-of-noninvasive-ventilation-devices-to-manage-respiratory-stability-of-patients.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
ResMed launches new nasal and full face masks